Trials / Completed
CompletedNCT02112539
Aggreguide A-100 ADP Assay Evaluation
Pivotal Study of the AggreGuide A-100 Adenosine Diphosphate (ADP) Assay to Evaluate the Effect of ADP Blocking Drugs on Platelet Aggregation on the AggreGuide A-100 Instrument
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 150 (actual)
- Sponsor
- Aggredyne, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
The study is to characterize the AggreGuide ADP Assay's performance.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | platelet aggregation measurement |
Timeline
- Start date
- 2014-03-01
- Primary completion
- 2014-08-01
- Completion
- 2014-08-01
- First posted
- 2014-04-14
- Last updated
- 2017-04-04
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02112539. Inclusion in this directory is not an endorsement.